Learn key facts about generic vs branded medicines, including pricing, ingredients, and approval standards worldwide. John Roberts issues warning on Supreme Court overruling precedent A blocked camera ...

The era of cheap, officially approved semaglutide is finally here—in Canada, that is. The country has just become the first in North America and the first G7 nation to license a generic version of the ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation and legislation. He is also the author of the morning Pharmalittle newsletter ...

Type to search articles, cases, and authors. Press ↵ to view all results. Hikma Pharmaceuticals USA v Amarin Pharma presents a complex dispute between Amarin, the manufacturer of Vascepa, a ...

Tesla is no longer the best carmaker in terms of EV technology, with the German car industry being fast to catch up. After the BMW i3 demonstrated genuine EV technology supremacy, Mercedes-Benz is ...

I was under the impression that Mercedes learned everything they could from their EQ brand fiasco, and that new and upcoming battery electric models would look more ...

April 13 (Reuters) - Teva Pharmaceutical (TEVA.TA), opens new tab must face a lawsuit claiming it used unlawful methods to block generic competition for its multiple sclerosis drug Copaxone, a New ...

Generic dapagliflozin is indicated for adults with type 2 diabetes and to reduce heart failure hospitalization risk in adults with T2D and established cardiovascular disease. The Food and Drug ...

The FDA has approved the first generic versions of Farxiga, a drug used to treat Type 2 diabetes and reduce the risk of hospitalization for heart failure. The generic, dapagliflozin, is indicated to ...

Generic dapagliflozin is indicated to lower heart failure hospitalization risk in type 2 diabetes with established cardiovascular disease or multiple risk factors, and to improve glycemic control ...

The FDA approved the first generics of dapagliflozin (Farxiga) tablets for adults with type 2 diabetes, the agency announced on Tuesday. Generics of the SGLT2 inhibitor are indicated for glycemic ...